Volume 25, Issue 13, Pages e2 (December 2018)

Slides:



Advertisements
Similar presentations
Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration- resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo 
Advertisements

Volume 23, Issue 2, Pages (February 2013)
Volume 21, Issue 3, Pages (March 2012)
Molecular Therapy - Nucleic Acids
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Volume 21, Issue 12, Pages (December 2017)
Volume 24, Issue 5, Pages (November 2013)
Volume 18, Issue 8, Pages (February 2017)
Volume 133, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2004)
Ming Hong Shen, Paulina Samsel, Louise L
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
The Requirement for Cyclin D Function in Tumor Maintenance
Mutant IDH1 Promotes Glioma Formation In Vivo
Volume 8, Issue 5, Pages (September 2014)
Volume 25, Issue 4, Pages (April 2014)
Volume 28, Issue 3, Pages (September 2015)
Volume 15, Issue 2, Pages (February 2009)
Volume 8, Issue 6, Pages (December 2005)
Volume 8, Issue 6, Pages (September 2014)
Volume 6, Issue 1, Pages (January 2014)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Jiping Yue, Xuewen Gou, Yuanyuan Li, Barton Wicksteed, Xiaoyang Wu 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Volume 33, Issue 2, Pages e4 (February 2018)
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis 
AKT1 Activation Promotes Development of Melanoma Metastases
Volume 7, Issue 6, Pages (June 2014)
Volume 27, Issue 1, Pages (January 2015)
Volume 15, Issue 4, Pages (April 2016)
Volume 21, Issue 3, Pages (March 2012)
ARAP3 Is a PI3K- and Rap-Regulated GAP for RhoA
Volume 21, Issue 12, Pages (December 2017)
Volume 19, Issue 6, Pages (June 2011)
Volume 20, Issue 6, Pages (December 2011)
Volume 40, Issue 3, Pages e5 (February 2017)
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Volume 6, Issue 1, Pages (January 2014)
Volume 22, Issue 3, Pages (September 2012)
Volume 2, Issue 6, Pages (December 2002)
Volume 129, Issue 5, Pages (June 2007)
Volume 47, Issue 6, Pages e6 (December 2017)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
Volume 18, Issue 12, Pages (March 2017)
Volume 20, Issue 3, Pages (July 2017)
Volume 18, Issue 8, Pages (February 2017)
Volume 17, Issue 2, Pages (October 2016)
Volume 8, Issue 4, Pages (October 2005)
Volume 16, Issue 2, Pages (February 2009)
Volume 12, Issue 4, Pages (July 2015)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 13, Issue 10, Pages (December 2015)
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Livio Trusolino, Andrea Bertotti, Paolo M Comoglio  Cell 
Volume 8, Issue 5, Pages (September 2014)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Volume 25, Issue 11, Pages e6 (December 2018)
Volume 18, Issue 3, Pages (September 2010)
Volume 10, Issue 9, Pages (March 2015)
Volume 7, Issue 3, Pages (March 2005)
Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 89, Issue 3, Pages (May 1997)
Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression  Jun-Li Luo, Shin.
Effects of ZOL treatment on pulmonary metastases.
GCS-100 selectively kills KRAS-addicted lung tumors.
Anticancer Activity of the Cholesterol Exporter ABCA1 Gene
Presentation transcript:

Volume 25, Issue 13, Pages 3545-3553.e2 (December 2018) Disruption of the Interaction of RAS with PI 3-Kinase Induces Regression of EGFR- Mutant-Driven Lung Cancer  Miguel M. Murillo, Sareena Rana, Bradley Spencer-Dene, Emma Nye, Gordon Stamp, Julian Downward  Cell Reports  Volume 25, Issue 13, Pages 3545-3553.e2 (December 2018) DOI: 10.1016/j.celrep.2018.12.003 Copyright © 2018 The Author(s) Terms and Conditions

Cell Reports 2018 25, 3545-3553.e2DOI: (10.1016/j.celrep.2018.12.003) Copyright © 2018 The Author(s) Terms and Conditions

Figure 1 Expression of RAS-Binding Domain-Mutant p110α in EGFR-Mutant Lung Cancer Cells Impairs Growth and Inhibits the Activation of AKT (A) Pik3caWT/Flox and Pik3caMUT/Flox MEFs (expressing ROSA26 Cre-ER) were treated overnight with 1 μM tamoxifen or vehicle to generate Pik3caWT/− and Pik3caMUT/− MEFs. Cells were starved overnight and stimulated for 10 min with epidermal growth factor (EGF) (10 ng/mL) or vehicle. Proteins were collected and subjected to western blot analysis as indicated. One representative experiment from three is shown. (B and E) PC9 (B) and H1975 (E) EGFR-mutant lung cancer cells were infected with retroviruses encoding Pik3caWT or Pik3caMUT or not infected (parental). Cells were then starved and stimulated with EGF (10 ng/mL) or vehicle for 10 min. Proteins were collected and subjected to western blot analysis as indicated. One representative experiment from three is shown. (C) Quantification of the western blots in (B) (n = 3). (F) Quantification of the western blots in (E) (n = 3). (D and G) Cell growth assay by crystal violet staining in PC9 (D) and H1975 (G) cells expressing Pik3caWT, Pik3caMUT or none (parental). Means of three replicates are shown. Cell Reports 2018 25, 3545-3553.e2DOI: (10.1016/j.celrep.2018.12.003) Copyright © 2018 The Author(s) Terms and Conditions

Figure 2 Disrupting the RAS-PI3K Interaction Impairs RAC1 Activation and Reduces Tumor Growth (A) Parental H1975 cells and H1975 cells expressing Pik3caWT or Pik3caMUT were starved overnight and stimulated with EGF (10 ng/mL) for the indicated times. Protein extracts were subjected to a RAC1 activation assay. One representative experiment from three is shown. (B) Quantification of western blot in (C). The ratio of RAC1-GTP to total RAC1 is shown, normalized to the value at time 0. (C and D) PC9 (C) and H1975 (D) parental cell lines and cells expressing either Pik3caWT or Pik3caMUT were injected into the flanks of nude mice (50,000 cells per mouse). The cells also contain a luciferase-expressing vector. Cells were allowed to grow, and tumor burden was measured by bioluminescence emission for the length of the experiment. (E and F) PC9 (E) and H1975 (F) parental cell lines and cells expressing either a wild-type RAC1 or a dominant-negative version (RAC1N17) were injected into the flanks of nude mice (50,000 cells per mouse). The cells also contain a luciferase-expressing vector. Cells were allowed to grow, and tumor burden was measured by bioluminescence emission for the length of the experiment. Means of three replicates are shown (C–F). Cell Reports 2018 25, 3545-3553.e2DOI: (10.1016/j.celrep.2018.12.003) Copyright © 2018 The Author(s) Terms and Conditions

Figure 3 EGFR-Mutant Lung Tumors Lacking the RAS-PI3K Interaction Show Strongly Delayed Development (A) Volume of air remaining in mouse lungs after tamoxifen (2 weeks) and doxycycline diet at different time points (n = 26 for Pik3caWT/− and n = 21 for Pik3caMUT/−). (B) Representative examples of lungs visualized by micro-CT scan (left), ex-vivo view (middle), and histological sections stained with H&E after 18 weeks of a doxycycline diet. (C) Quantification of the number of tumor foci per lung after 18 weeks of a doxycycline diet from histological samples (n = 7 per group). (D) Quantification of the area of the lung occupied by tumor foci after 18 weeks of a doxycycline diet from histological samples (n = 7 per group). (E) Representative examples of proliferation in tumor samples visualized by Ki-67 staining. Scale bar, 100 μm. (F) Quantification of proliferation by Ki-67 staining (n = 6 per group). (G) Survival assay. The endpoint was dictated by defined welfare severity limits: moderately increased respiratory rate and/or moderately hunched appearance (n = 11 for Pik3caWT/Flox, n = 11 for Pik3caWT/−, and n = 15 for Pik3caMUT/−). Cell Reports 2018 25, 3545-3553.e2DOI: (10.1016/j.celrep.2018.12.003) Copyright © 2018 The Author(s) Terms and Conditions

Figure 4 Removal of the RAS-PI3K Interaction Causes Major Regression of Established EGFR-Mutant Lung Tumors (A) Volume of air remaining in the lungs of mice after a doxycycline diet at different time points with (Pik3caWT/− and Pik3caMUT/−) or without (Pik3caWT/Flox and Pik3caMUT/Flox) 2 weeks of tamoxifen treatment starting at week 11. Animal numbers are n = 17 (Pik3caWT/Flox) and n = 15 (Pik3caMUT/Flox) from week 0 to week 11 and n = 7 (Pik3caWT/Flox), n = 9 (Pik3caMUT/Flox), n = 10 (Pik3caWT/−), and n = 6 (Pik3caMUT/−) from week 13 to the end of the experiment. (B) Representative examples of micro-CT scans (left three columns) and histological sections stained with H&E (right panel) after 18 weeks of a doxycycline diet. Scale bar, 1 mm. (C) Number of tumor foci (nodules) per lung quantified from histological samples (n = 7 per group). (D) Representative examples of apoptosis visualized by TUNEL staining in histological samples. Scale bar, 100 μm. (E) Quantification of apoptosis by TUNEL staining (n = 20 for each group). (F) Representative examples of proliferation visualized by Ki-67 staining in histological samples. Scale bar, 100 μm. (G) Quantification of proliferation by Ki-67 staining (n = 20 for Pik3caWT/− and n = 19 for Pik3caMUT/−). Cell Reports 2018 25, 3545-3553.e2DOI: (10.1016/j.celrep.2018.12.003) Copyright © 2018 The Author(s) Terms and Conditions